Activity
-
Can LLM's allow us to leave standards behind? "Do We Need Data Standards in the Era of Large Language Models?" @NEJM_AI https://lnkd.in/ea3tqtBG…
Can LLM's allow us to leave standards behind? "Do We Need Data Standards in the Era of Large Language Models?" @NEJM_AI https://lnkd.in/ea3tqtBG…
Liked by Iya Khalil
-
The burgeoning integration of AI into single-cell discovery has intensified the demand for extensive training datasets. For these technologies to…
The burgeoning integration of AI into single-cell discovery has intensified the demand for extensive training datasets. For these technologies to…
Liked by Iya Khalil
-
I'm happy to share a report co-authored by my good friend and colleague, Bradford Gibson Precision medicine, with its focus on tailoring disease…
I'm happy to share a report co-authored by my good friend and colleague, Bradford Gibson Precision medicine, with its focus on tailoring disease…
Liked by Iya Khalil
Experience & Education
-
Merck
View Iya’s full experience
See their title, tenure and more.
or
Publications
-
Bayesian network inference modeling identifies TRIB1 as a novel regulator of cell cycle progression and survival in cancer cells.
Cancer Research
Other authors -
-
Bayesian Network Models of Multiple Myeloma: Drivers of High Risk and Durable Response.
ASH Annual Meeting
Other authors -
-
Data-Driven Reconstruction and Simulation of Transcriptional Regulatory Networks in the Htt Allelic Series.
CHDI Foundation, Inc.‘s 11th Annual HD Therapeutics Conference
Other authors -
-
Identification of Clinical and Genetic Predictors of Parkinson’s Disease Progression via Bayesian Machine Learning.
World Parkinson’s Congress
Other authors -
-
Using Clinical Trial and Real World Data to Bridge Efficacy to Effectiveness of Fingolimod in Multiple Sclerosis Patients.
ISPOR
Other authors -
-
Investigation of Mechanisms of Response in Multiple Myeloma Via Bayesian Causal Inference: An Early Analysis of the CoMMpass Study Data
American Society of Hematology (ASH) 57th Annual Meeting & Exposition
Other authors -
-
Power of Reverse Engineering and Forward Simulation Platform for Driving Precision Medicine
Pharmaceutical R&D Information Systems Management Executive Forum
-
A mathematical model of long-term outcomes in Parkinson’s disease
17th International Congress of Parkinson’s Disease and Movement Disorders
Other authors -
-
Data-driven computational modeling to identify biomarkers of response to lenvatinib (E7080) in melanoma
104th Annual Meeting of the American Association for Cancer Research
Other authors -
-
Reverse-engineered, forward-simulation of MEK-dependent molecular networks reveal novel regulators of cell cycle and cancer cell survival.
103rd Annual Meeting of the American Association for Cancer Research
Other authors -
-
Causal modeling using network ensemble simulations of genetic and gene expression data predicts genes involved in rheumatoid arthritis
PLoS Comput Biol
Other authors -
-
Quantification and analysis of combination drug synergy in high-throughput transcriptome studies.
IEEE International Conference on Bioinformatics and Bioengineering
Other authors -
-
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer
. Gynecol Oncol
Other authors -
-
A systems biology dynamical model of mammalian G1 cell cycle progression
Mol Syst Biol
Other authors -
-
Achieving confidence in mechanism for drug discovery and development
Drug Discov Today
Other authors -
-
An integrated approach for inference and mechanistic modeling for advancing drug development.
FEBS Lett
Other authors -
-
Systems biology for cancer
Curr Opin Oncol
Other authors -
-
Data-driven computer simulation of human cancer cell
Acad Sci
Other authors -
-
HD causal modeling using network ensemble simulations of gene expression data
CHDI Foundation, Inc.‘s Annual HD Therapeutics Conference.
Other authors -
Patents
-
Systems and Methods for Modeling and Analyzing Networks
Issued US 8,571,803
The patent covers key methods underlying REFS™, a computational platform that automatically builds predictive and explanatory models from big data
Honors & Awards
-
PharmaVoice 100 Most Inspiring People
PharmaVoice
Recognized for her ability to build bridges across the life-science and healthcare industries, bringing people together to harness the power of predictive modeling to change the lives of patients.
-
Honored by President Obama
White House
President Obama recognized Dr. Khalil as a pioneer in genomic medicine during a 2013 White House dinner.
-
Top 10 Biotech Techies
Fierce Biotech
-
Andersen Prize for Outstanding Undergraduate Physics Student
University of Washington
Organizations
-
Healthcare Businesswomen's Association
-
-
Springboard Alumna
-
-
Women Business Leaders
-
More activity by Iya
-
Bigger Leaps.... 🚀 After an incredible journey at Microsoft, I'm excited to announce my transition to Flagship Pioneering. Stepping from my…
Bigger Leaps.... 🚀 After an incredible journey at Microsoft, I'm excited to announce my transition to Flagship Pioneering. Stepping from my…
Liked by Iya Khalil
-
We've been learning a ton and making tools for measuring groundedness of, and detecting hallucinations in, LLM responses. And the heavy internal and…
We've been learning a ton and making tools for measuring groundedness of, and detecting hallucinations in, LLM responses. And the heavy internal and…
Liked by Iya Khalil
-
I think we may be approaching a tipping point in AI for medical imaging. Incredible progress at the @CVPR workshop on foundation models for medical…
I think we may be approaching a tipping point in AI for medical imaging. Incredible progress at the @CVPR workshop on foundation models for medical…
Liked by Iya Khalil
Other similar profiles
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More